Analysing the efficacy of clozapine

S. Ahmer

Tony Hillis Wing, West London Mental Health NHS Trust, Uxbridge Road, Southall, Middlesex UB1 3EU, UK

It is interesting to note that while all the participants in the debate on clozapine v. typical neuroleptics referred to Kristian Wahlbeck’s meta-analysis (Wahlbeck et al, 2000), none of them referred to her sub-analysis of her own earlier meta-analysis on this topic (Wahlbeck & Adams, 1999). In this subanalysis, all randomised trials comparing clozapine with typical neuroleptic medication for schizophrenia were divided into sponsored (reporting some kind of connection with manufacturers of clozapine) and non-sponsored trials. Odds ratios and 95% confidence intervals were calculated for the primary outcomes of relapse, clinical improvement, and leaving the study early, separately for sponsored and non-sponsored studies. Odds of relapsing were significantly in favour of clozapine in the sponsored trials (OR=0.5, 95% CI 0.3–0.7). Non-sponsored studies reported equivocal findings (OR=0.4, 95% CI 0.1–1.4). Similarly, sponsored studies showed a significant difference in favour of clozapine on the outcome measure of leaving the study early (OR=0.5, 95% CI 0.4–0.7). Non-sponsored studies showed a non-significant difference (OR=0.6, CI 0.3–1.2). Only on the outcome measure of improvement did both sponsored and non-sponsored studies show a significant benefit of clozapine over older antipsychotics. Wahlbeck suggested that those undertaking meta-analysis of drug treatment should investigate for sponsorship bias by using sensitivity analysis.

Outside of psychiatry, similar associations between sponsorship and outcome of trials has been demonstrated in randomised controlled trials (RCTs) published in five general medical journals (Davidson, 1986; Yaphe et al, 2001), RCTs of nonsteroidal anti-inflammatory drugs in the treatment of arthritis (Rochon et al, 1994) and RCTs published in the BMJ over 41/2 years (Kjaergard & Als-Nielsen, 2002).

Although RCTs and meta-analyses have contributed greatly to increasing our knowledge base about which treatments work and which do not, maybe it is time we began to consider other factors that might explain the observed difference between two treatments in RCTs and meta-analyses, beyond the standard critical appraisal questions. Maybe we need to ask not only how the efficacy of clozapine (or any other drug for that matter) has been analysed but also who has analysed it.

REFERENCES

Davidson, R. A. (1986) Source of funding and outcome of clinical trials. Journal of General Internal Medicine, 1, 155 -158.[Medline]

Kjaergard, L. L. & Als-Nielsen, B. (2002) Association between competing interests and authors’ conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ, 325, 249 -253.[Abstract/Free Full Text]

Rochon, P. A., Gurwitz, J. H., Simms, R., et al (1994) A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Archives of Internal Medicine, 154, 157 -163.[Abstract]

Wahlbeck, K. & Adams, C. (1999) Beyond conflict of interest. Sponsored drug trials show more favourable outcomes (letter). BMJ, 318, 465 .[Medline]

Wahlbeck, K., Cheine, M., Essali, A., et al (2000) Clozapine versus typical neuroleptic medication for schizophrenia. Cochrane Library, issue 3. Oxford: Update Software.

Yaphe, J., Richard, E., Knishkowy, B., et al (2001) The association between funding by commercial interests and study outcome in randomized controlled drug trials. Family Practice, 18, 565 -568.[Abstract/Free Full Text]





This Article
Full Text (PDF)
Submit a response
Alert me when this article is cited
Alert me when eLetters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Ahmer, S.
Articles citing this Article
PubMed
PubMed Citation
Articles by Ahmer, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals